GlyCosmos Portal

GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source	Last Updated
PSICQUIC	March 30, 2022

Displaying entries **1626 - 1650** of **4050** in total

« First

‹ Prev

…

62

63

64

65

66

67

68

69

70

…

Next ›

Last »
Antibody	Patient	Onset (days)	Symptom	GlyTouCan ID	Arbitrary Fluorescence Units (AFU) ▲
IgG	Patient 4	12	mild	G16579HJ	134
IgG	Patient 3	11	mild	G17266GE	135
IgG	Patient 4	12	mild	G25407RZ	136
IgM	Patient 4	12	mild	G61751GZ	136
IgM	Patient 2	15	mild	G17390SF	137
IgG	Patient 3	4	mild	G09482NW	137
IgM	Patient 4	12	mild	G00054MO	137
IgM	Patient 2	15	mild	G02670IJ	138
IgM	Patient 2	3	mild	G96865DJ	138
IgM	Patient 3	-180	mild	G02670IJ	139
IgM	Patient 3	4	mild	G76355TG	139
IgM	Patient 3	4	mild	G96881BQ	139
IgG	Patient 4	12	mild	G68703KI	139
IgM	Patient 4	12	mild	G22768VO	139
IgM	Patient 4	12	mild	G32611KT	139
IgM	Patient 3	-180	mild	G32699RJ	140
IgM	Patient 3	11	mild	G53168IY	140
IgM	Patient 3	11	mild	G78255UI	140
IgM	Patient 3	4	mild	G00052MO	140
IgG	Patient 1	10	moderate	G71142DF	141
IgG	Patient 3	-180	mild	G35446HX	141
IgG	Patient 3	4	mild	G17266GE	141
IgM	Patient 3	11	mild	G96881BQ	141
IgM	Patient 3	4	mild	G36191CD	141
IgM	Patient 1	22	moderate	G32473MI	142